Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Scherer

Showing results (261-270 of 333) with videos related to

Pageof 34
Sort By:
Stem Cells (Dayton, Ohio)|July 12, 2012
Tumor-initiating cells of various tumor types exhibit differential angiogenic properties and react differently to antiangiogenic drugsLiat Benayoun, Svetlana Gingis-Velitski, Tali Voloshin, et al.
Sarcoma|June 4, 2008
Absence of telomerase activity in malignant bone tumors and soft-tissue sarcomasNina K Lauer, Sandra M Maier, Martin Oberringer, et al.
Acta Psychiatrica Scandinavica|July 1, 1984
Adverse drug reactions. An epidemiological study at psychiatric hospitalsL G Schmidt, R Grohmann, H Helmchen, et al.
Chemical Communications (Cambridge, England)|December 7, 2010
Predicting the influence of a p2-symmetric substrate on molecular self-organization with an interaction-site modelCarsten Rohr, Marta Balbás Gambra, Kathrin Gruber, et al.
Journal of the American Chemical Society|September 30, 2009
Deprotection, tethering, and activation of a one-legged metalloporphyrin on a chemically active metal surface: NEXAFS, synchrotron XPS, and STM study of [SAc]P-Mn(III)Cl on Ag(100)Mark Turner, Owain P H Vaughan, Georgios Kyriakou, et al.
Journal of Molecular and Cellular Cardiology|February 14, 2012
Cancer therapy modulates VEGF signaling and viability in adult rat cardiac microvascular endothelial cells and cardiomyocytesManuel Chiusa, Sara-Lynn Hool, Petra Truetsch, et al.
British Journal of Cancer|April 1, 2016
Evaluation of Angiopoietin-2 as a biomarker in gastric cancer: results from the randomised phase III AVAGAST trialUlrich T Hacker, Laura Escalona-Espinosa, Nicola Consalvo, et al.
The Analyst|June 16, 2015
Incorporation of a FRET dye pair into mesoporous materials: a comparison of fluorescence spectra, FRET activity and dye accessibilitySusanne Widmer, Michael J Reber, Patrick Müller, et al.
The Journal of Biological Chemistry|September 14, 2000
p53 and c-Jun functionally synergize in the regulation of the DNA repair gene hMSH2 in response to UVS J Scherer, S M Maier, M Seifert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2012
Predictive impact of circulating vascular endothelial growth factor in four phase III trials evaluating bevacizumabPriti S Hegde, Adrian M Jubb, Dafeng Chen, et al.
Pageof 34

Showing results (261-270 of 333) with videos related to

Sort By:
Pageof 34
Stem Cells (Dayton, Ohio)|July 12, 2012
Tumor-initiating cells of various tumor types exhibit differential angiogenic properties and react differently to antiangiogenic drugsLiat Benayoun, Svetlana Gingis-Velitski, Tali Voloshin, et al.
Sarcoma|June 4, 2008
Absence of telomerase activity in malignant bone tumors and soft-tissue sarcomasNina K Lauer, Sandra M Maier, Martin Oberringer, et al.
Acta Psychiatrica Scandinavica|July 1, 1984
Adverse drug reactions. An epidemiological study at psychiatric hospitalsL G Schmidt, R Grohmann, H Helmchen, et al.
Chemical Communications (Cambridge, England)|December 7, 2010
Predicting the influence of a p2-symmetric substrate on molecular self-organization with an interaction-site modelCarsten Rohr, Marta Balbás Gambra, Kathrin Gruber, et al.
Journal of the American Chemical Society|September 30, 2009
Deprotection, tethering, and activation of a one-legged metalloporphyrin on a chemically active metal surface: NEXAFS, synchrotron XPS, and STM study of [SAc]P-Mn(III)Cl on Ag(100)Mark Turner, Owain P H Vaughan, Georgios Kyriakou, et al.
Journal of Molecular and Cellular Cardiology|February 14, 2012
Cancer therapy modulates VEGF signaling and viability in adult rat cardiac microvascular endothelial cells and cardiomyocytesManuel Chiusa, Sara-Lynn Hool, Petra Truetsch, et al.
British Journal of Cancer|April 1, 2016
Evaluation of Angiopoietin-2 as a biomarker in gastric cancer: results from the randomised phase III AVAGAST trialUlrich T Hacker, Laura Escalona-Espinosa, Nicola Consalvo, et al.
The Analyst|June 16, 2015
Incorporation of a FRET dye pair into mesoporous materials: a comparison of fluorescence spectra, FRET activity and dye accessibilitySusanne Widmer, Michael J Reber, Patrick Müller, et al.
The Journal of Biological Chemistry|September 14, 2000
p53 and c-Jun functionally synergize in the regulation of the DNA repair gene hMSH2 in response to UVS J Scherer, S M Maier, M Seifert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2012
Predictive impact of circulating vascular endothelial growth factor in four phase III trials evaluating bevacizumabPriti S Hegde, Adrian M Jubb, Dafeng Chen, et al.
Pageof 34